169 related articles for article (PubMed ID: 36081396)
1. Metabolic syndrome, obesity and cancer risk.
Belladelli F; Montorsi F; Martini A
Curr Opin Urol; 2022 Nov; 32(6):594-597. PubMed ID: 36081396
[TBL] [Abstract][Full Text] [Related]
2. Obesity, metabolic syndrome, and prostate cancer.
Hsing AW; Sakoda LC; Chua S
Am J Clin Nutr; 2007 Sep; 86(3):s843-57. PubMed ID: 18265478
[TBL] [Abstract][Full Text] [Related]
3. Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: a systematic review.
Cantiello F; Cicione A; Salonia A; Autorino R; De Nunzio C; Briganti A; Gandaglia G; Dell'Oglio P; Capogrosso P; Damiano R
Int J Urol; 2015 Jan; 22(1):22-32. PubMed ID: 25345683
[TBL] [Abstract][Full Text] [Related]
4. Association of sleep disturbances with obesity, insulin resistance and the metabolic syndrome.
Koren D; Taveras EM
Metabolism; 2018 Jul; 84():67-75. PubMed ID: 29630921
[TBL] [Abstract][Full Text] [Related]
5. Role of Metabolic Syndrome in Prostate Cancer Development.
Lifshitz K; Ber Y; Margel D
Eur Urol Focus; 2021 May; 7(3):508-512. PubMed ID: 33994167
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome identifies normal weight insulin-resistant stroke patients at risk for recurrent vascular disease.
Dearborn JL; Viscoli CM; Inzucchi SE; Young LH; Kernan WN
Int J Stroke; 2019 Aug; 14(6):639-645. PubMed ID: 30507360
[TBL] [Abstract][Full Text] [Related]
7. Impact of metabolic syndrome on the risk of endometrial cancer and the role of lifestyle in prevention.
Pérez-Martín AR; Castro-Eguiluz D; Cetina-Pérez L; Velasco-Torres Y; Bahena-González A; Montes-Servín E; González-Ibarra E; Espinosa-Romero R; Gallardo-Rincón D
Bosn J Basic Med Sci; 2022 Jul; 22(4):499-510. PubMed ID: 35276057
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer.
Gallagher EJ; LeRoith D
Diabetes Care; 2013 Aug; 36 Suppl 2(Suppl 2):S233-9. PubMed ID: 23882051
[No Abstract] [Full Text] [Related]
9. Urological aspects of the metabolic syndrome.
Hammarsten J; Peeker R
Nat Rev Urol; 2011 Aug; 8(9):483-94. PubMed ID: 21811224
[TBL] [Abstract][Full Text] [Related]
10. Metabolic obesity phenotypes and risk of colorectal cancer in postmenopausal women.
Kabat GC; Kim MY; Stefanick M; Ho GYF; Lane DS; Odegaard AO; Simon MS; Bea JW; Luo J; Wassertheil-Smoller S; Rohan TE
Int J Cancer; 2018 Aug; 143(3):543-551. PubMed ID: 29488210
[TBL] [Abstract][Full Text] [Related]
11. Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer.
Hammarsten J; Högstedt B
Blood Press; 2004; 13(1):47-55. PubMed ID: 15083641
[TBL] [Abstract][Full Text] [Related]
12. [Sex steroids and adipokines in men with prostate cancer and their relationship with obesity and metabolic syndrome].
Borowski A; Siemińska L
Wiad Lek; 2020; 73(1):180-187. PubMed ID: 32124831
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome and risk of cancer: a systematic review and meta-analysis.
Esposito K; Chiodini P; Colao A; Lenzi A; Giugliano D
Diabetes Care; 2012 Nov; 35(11):2402-11. PubMed ID: 23093685
[TBL] [Abstract][Full Text] [Related]
14. Obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver.
Sung KC; Lee MY; Kim YH; Huh JH; Kim JY; Wild SH; Byrne CD
Atherosclerosis; 2018 Aug; 275():50-57. PubMed ID: 29860108
[TBL] [Abstract][Full Text] [Related]
15. Associations of metabolic syndrome and C-reactive protein with mortality from total cancer, obesity-linked cancers and breast cancer among women in NHANES III.
Gathirua-Mwangi WG; Song Y; Monahan PO; Champion VL; Zollinger TW
Int J Cancer; 2018 Aug; 143(3):535-542. PubMed ID: 29488212
[TBL] [Abstract][Full Text] [Related]
16. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
Jeanes YM; Reeves S
Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome.
Bray GA; Bellanger T
Endocrine; 2006 Feb; 29(1):109-17. PubMed ID: 16622298
[TBL] [Abstract][Full Text] [Related]
18. [Obesity, metabolic syndrome].
Shiga T
Nihon Rinsho; 2016 Aug; 74(8):1334-1338. PubMed ID: 30562438
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological and molecular mechanisms aspects linking obesity and cancer.
Osório-Costa F; Rocha GZ; Dias MM; Carvalheira JB
Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):213-26. PubMed ID: 19466214
[TBL] [Abstract][Full Text] [Related]
20. Metabolically Healthy and Unhealthy Normal Weight and Obesity.
Stefan N
Endocrinol Metab (Seoul); 2020 Sep; 35(3):487-493. PubMed ID: 32814419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
